Clinical Trial Update: Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chidamide in combination with ICE chemotherapy for relapsed/refractory peripheral T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Chidamide (chidamide)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: Yuankai Shi | Conditions: Peripheral T Cell Lymphoma | Phase 2 | Status: UNKNOWN